AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment
AIM ImmunoTech Inc. (NYSE American: AIM) has announced that its Chief Executive Officer, Thomas K. Equels, will participate in a Virtual Investor CEO Connect segment on Wednesday, October 2, 2024, at 4:00 PM ET. The event will feature a brief presentation by Mr. Equels, followed by an interactive Q&A session.
Investors and interested parties can submit questions live during the event or pre-submit them via email to AIM@jtcir.com. A live video webcast of the presentation will be available on the Events page of the Company's website (aimimmuno.com). A webcast replay will be accessible for 90 days, starting two hours after the live presentation.
AIM ImmunoTech Inc. (NYSE American: AIM) ha annunciato che il suo amministratore delegato, Thomas K. Equels, parteciperà a un segmento Virtual Investor CEO Connect il mercoledì 2 ottobre 2024, alle 16:00 ET. L'evento prevede una breve presentazione da parte del sig. Equels, seguita da una sessione interattiva di domande e risposte.
Gli investitori e gli interessati possono inviare domande dal vivo durante l'evento o inviarle in anticipo via email a AIM@jtcir.com. Un webcast video in diretta della presentazione sarà disponibile nella pagina Eventi del sito web della Società (aimimmuno.com). Una registrazione del webcast sarà accessibile per 90 giorni, a partire da due ore dopo la presentazione dal vivo.
AIM ImmunoTech Inc. (NYSE American: AIM) ha anunciado que su director ejecutivo, Thomas K. Equels, participará en un segmento de Virtual Investor CEO Connect el miércoles 2 de octubre de 2024 a las 4:00 PM ET. El evento contará con una breve presentación del Sr. Equels, seguida de una sesión interactiva de preguntas y respuestas.
Los inversores y partes interesadas pueden enviar preguntas en vivo durante el evento o enviarlas previamente por correo electrónico a AIM@jtcir.com. Un webcast en video en vivo de la presentación estará disponible en la página de Eventos del sitio web de la Compañía (aimimmuno.com). Una repetición del webcast estará accesible durante 90 días, comenzando dos horas después de la presentación en vivo.
AIM ImmunoTech Inc. (NYSE American: AIM)는 최고경영자(CEO) Thomas K. Equels가 2024년 10월 2일 수요일 오후 4시 ET에 Virtual Investor CEO Connect에 참여할 것이라고 발표했습니다. 이 행사에서는 Equels 씨의 간략한 발표가 있을 예정이며, 이후에는 인터랙티브 Q&A 세션이 진행됩니다.
투자자와 관심 있는 분들은 행사 중 실시간으로 질문을 제출하거나 AIM@jtcir.com으로 이메일을 통해 사전 제출할 수 있습니다. 발표의 실시간 비디오 웹캐스트는 회사 웹사이트의 이벤트 페이지(aimimmuno.com)에서 볼 수 있습니다. 웹캐스트 재播放는 실시간 발표로부터 두 시간 후부터 90일 동안 이용 가능합니다.
AIM ImmunoTech Inc. (NYSE American: AIM) a annoncé que son directeur général, Thomas K. Equels, participera à un segment Virtual Investor CEO Connect le mercredi 2 octobre 2024 à 16h00 ET. L'événement présentera une brève présentation de M. Equels, suivie d'une session de questions-réponses interactive.
Les investisseurs et les parties intéressées peuvent soumettre des questions en direct pendant l'événement ou les envoyer à l'avance par e-mail à AIM@jtcir.com. Un webcast vidéo en direct de la présentation sera disponible sur la page Événements du site Web de la Société (aimimmuno.com). Un replay du webcast sera accessible pendant 90 jours, à partir de deux heures après la présentation en direct.
AIM ImmunoTech Inc. (NYSE American: AIM) hat bekannt gegeben, dass der CEO Thomas K. Equels am Mittwoch, den 2. Oktober 2024, um 16:00 Uhr ET an einem Virtual Investor CEO Connect teilnehmen wird. Die Veranstaltung wird eine kurze Präsentation von Herrn Equels beinhalten, gefolgt von einer interaktiven Fragerunde.
Investoren und Interessierte können während der Veranstaltung live Fragen stellen oder diese vorab per E-Mail an AIM@jtcir.com einreichen. Ein live Video-Webcast der Präsentation wird auf der Veranstaltungsseite der Unternehmenswebsite (aimimmuno.com) verfügbar sein. Eine Webcast-Wiederholung wird für 90 Tage ab dem Zeitpunkt zwei Stunden nach der Live-Präsentation zugänglich sein.
- None.
- None.
Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, October 2nd at 4:00 PM ET
OCALA, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Thomas K. Equels, Chief Executive Officer of AIM will participate in a Virtual Investor CEO Connect segment on Wednesday, October 2, 2024 at 4:00 PM ET.
As part of the event, Mr. Equels will provide a brief presentation, followed by an interactive Q&A session. Investors and interested parties will have the opportunity to submit questions live during the event. Questions can also be pre-submitted leading up to the event by emailing AIM@jtcir.com. Mr. Equels will answer as many questions as possible in the time allowed.
A live video webcast of the presentation will be available on the Events page of the Company’s website (aimimmuno.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational drug called Ampligen® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system.
For more information, please visit aimimmuno.com and connect with the Company on X, LinkedIn, and Facebook.
FAQ
When is AIM ImmunoTech's CEO participating in the Virtual Investor CEO Connect segment?
How can investors submit questions for AIM ImmunoTech's CEO during the Virtual Investor event?
Where can I watch the live webcast of AIM ImmunoTech's Virtual Investor CEO Connect segment?
How long will the replay of AIM ImmunoTech's Virtual Investor CEO Connect segment be available?
